Algo version: 0.98b
Cyxone AB (publ) is listed at the STO Exchange
Cyxone AB (publ) [CYXO.ST]
STO Sector: Healthcare Industry:Biotechnology

Is Cyxone AB (publ) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Cyxone AB (publ) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK5.14, you would have made a loss of SEK-5.10 per share or -99.19%

No, the average daily trading liquidity for Cyxone AB (publ) is SEK1.36 million. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Cyxone AB (publ) has no real debt, which is good in periods of high inflation. Cyxone AB (publ) has a very good net profit margin of 4 657.99% and should have very high tolerances against inflation.

We have calculated the inflation risk for Cyxone AB (publ) to be low [0.3 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.